Form D · Pharmaceuticals
MADRIGAL PHARMACEUTICALS, INC.
West Conshohocken, PA · CIK 0001157601
Offering snapshot reported Jul 5, 2017 · SEC filing
- Reported sold
- $35M Offering amount: $35M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 23, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 5, 2017 | Initial | $35,000,018 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-289979
Series A Convertible Preferred Stock and Common Stock
Source: Form D, filed Jul 5, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kenneth M. Bate | Director |
| Fred B. Craves | Director |
| Paul A. Friedman | Director, Executive |
| Keith R. Gollust | Director |
| Richard S. Levy | Director |
| David Milligan | Director |
| Marc R. Schneebaum | Executive |
| Rebecca Taub | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
200 Barr Harbor Drive, Suite 400
West Conshohocken, PA, 19428
West Conshohocken, PA, 19428